ESC 365 - Structural progression increases the risk of ventricular arrhythmias in patients with arrhythmogenic cardiomyopathy

ESC Premium Access

Structural progression increases the risk of ventricular arrhythmias in patients with arrhythmogenic cardiomyopathy

Session: Hot topics in myocardial and pericardial diseases

Topic: Arrhythmogenic Right Ventricular Cardiomyopathy

Speaker: Doctor M. Chivulescu (Oslo, NO)

Event: ESC Congress 2019

Congress Presentation

About the speaker

Doctor Monica Chivulescu

LHL Hospital, Oslo, Oslo (Norway)

2 presentations

0 follower

8 more presentations in this session

Role of 18FDG(fluorodeoxyglucose)-PET (positron emission tomography) for differential diagnosis of pericardial disease

Speaker: Doctor C. Hyeon (Seoul, KR)

Interim analysis of data from a long-term, extension trial of tafamidis meglumine in patients with transthyretin amyloid cardiomyopathy

Speaker: Doctor S. Gottlieb (Baltimore, US)

Tafamidis versus liver transplantation as first-line therapy for hereditary transthyretin amyloidosis

Speaker: Doctor V. Algalarrondo (Paris, FR)

Myocardial perfusion mapping in cardiac amyloidosis- exploring the spectrum from infiltration to ischaemia

Speaker: Doctor T. Kotecha (London, GB)

The increased serum level of troponin T after immunosuppression therapy reflects sustained myocardial FDG accumulation in cardiac sarcoidosis

Speaker: Doctor R. Morimoto (Nagoya, JP)

Access the full session

Hot topics in myocardial and pericardial diseases

Speakers: Doctor M. Chivulescu, Doctor C. Hyeon, Doctor S. Gottlieb, Doctor V. Algalarrondo, Doctor T. Kotecha...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

Related content

Open Access

Mode of intervention in aortic stenosis.

28 August 2021

Open Access

Timing and indication of intervention in asymptomatic patients with valvular heart disease.

28 August 2021

ESC Premium Access

Changes in EPA and DHA during supplementation with Omega-3 fatty acids and incident cardiovascular events: secondary analysis from the OMEMI trial

27 August 2021

ESC 365 is supported by